Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) have been assigned a consensus rating of “Hold” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $117.00.
CHEOY has been the subject of several research analyst reports. Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Royal Bank Of Canada downgraded shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target for the company. in a research report on Thursday, July 16th. Zacks Research upgraded shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, Canaccord Genuity Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th.
Get Our Latest Stock Report on CochLear
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
